No abstract available
Keywords:
First-line treatment; MET fusion; MET inhibitor; Next-generation sequencing; Non-small cell lung cancer.
MeSH terms
-
Carcinoma, Non-Small-Cell Lung* / drug therapy
-
Carcinoma, Non-Small-Cell Lung* / genetics
-
Crizotinib / therapeutic use
-
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit
-
Humans
-
Lung Neoplasms* / drug therapy
-
Lung Neoplasms* / genetics
-
Oncogene Proteins, Fusion / genetics
-
Protein Kinase Inhibitors / therapeutic use
-
Transcription Factors
Substances
-
Crizotinib
-
Protein Kinase Inhibitors
-
Transcription Factors
-
Oncogene Proteins, Fusion
-
PRKAR1A protein, human
-
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit